Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Oral contraceptives modify DNA methylation and monocyte-derived macrophage function.
Campesi I, Sanna M, Zinellu A, Carru C, Rubattu L, Bulzomi P, Seghieri G, Tonolo G, Palermo M, Rosano G, Marino M, Franconi F.
Biol Sex Differ. 2012 Jan 27;3:4.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C.
Contraception. 2007 Jun;75(6):430-7. Epub 2007 Mar 26.
Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
Greenlund KJ, Webber LS, Srinivasan S, Wattigney W, Johnson C, Berenson GS.
Ann Epidemiol. 1997 Nov;7(8):561-7.
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR.
Dan Med Bull. 2002 Feb;49(1):43-60. Review.
Contraceptive steroid effects on nonreproductive organ systems.
Corson SL.
J Reprod Med. 1986 Sep;31(9 Suppl):865-78.
The metabolic impact of oral contraceptives.
Krauss RM, Burkman RT Jr.
Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1177-84. Review.
Effect of oral contraceptive progestins on serum copper concentration.
Berg G, Kohlmeier L, Brenner H.
Eur J Clin Nutr. 1998 Oct;52(10):711-5.
[Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC.
Contracept Fertil Sex (Paris). 1991 Apr;19(4):285-8. French.
OC practice guidelines: minimizing side effects.
Darney PD.
Int J Fertil Womens Med. 1997;Suppl 1:158-69. Review.
Metabolic effects of oral contraceptives: fact vs. fiction.
[No authors listed]
Contracept Rep. 1996 Jan;6(6):4-14.
[Cutaneous effects in hormonal contraception].
Thomas P, Dalle E, Revillon B, Delecour M, Devarenne-nicolle MF, Pagniez I.
NPN Med. 1985 Jan 1;5(81):19-24. French.
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
Am J Obstet Gynecol. 1993 Nov;169(5):1183-9.
[Influence of progestins on adverse effects of oral contraceptives].
Wynn V.
Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):425-30. French.
Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
J Clin Endocrinol Metab. 1981 Dec;53(6):1123-32.
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
Thromb Haemost. 1995 Sep;74(3):928-32.
[Oral contraception: failures and risks].
Foussard-blanpin O, Paillot-renaud P, Bruneau-bigot A.
Lyon Pharm. 1984 Nov;35(6):385-93. French.
[Contraception for the diabetic woman].
Arlot S, Mesmacque A, Lalau JD, Quichaud J.
Fertil Contracept Sex. 1988 Nov;16(11):921-6. French.
[Metabolic risks of oral contraception].
Monier L.
Rev Int Pediatr. 1988 Feb;(178):64-5. French.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on